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Main points 
 
This series of reports presents an assessment of the extent of COVID-19-related impact on 
childhood vaccinations based on both (a) aggregated vaccine counts of dose 1 Hexavalent and 
dose 1 MMR vaccinations delivered to infants or children and (b) vaccine coverage data for 
dose 1, 2 and 3 Hexavalent and dose 1 MMR vaccines extracted from ImmForm. 
 
This eleventh report, that includes vaccination counts data up to week 4 in 2021, and vaccine 
coverage data up to December 2020.  
 
Vaccination counts 
Vaccination counts for the first dose of Hexavalent (DTaP/IPV/Hib/HepB) in children aged 6 
months and the first dose of MMR (Measles, Mumps, Rubella) in children aged 12 to 18 months 
were extracted from The Phoenix Partnership, which represents data from approximately 38% 
of GP practices in England. Vaccination counts to December indicate that: 
 
• Hexavalent and MMR vaccination counts fell at the time of introduction of physical 
distancing measures in March 2020 (week 13) compared to the same period in 2019. 
This was followed by a rise from weeks 16 onwards which has stabilised and is 
comparable to vaccination counts prior to the COVID-19 pandemic 
• in 2020, the number of counts continued to stabilise, though there have been slightly 
lower vaccination counts throughout the tiered restrictions (weeks 43 to 45) and the 
second national lockdown in the autumn (week 45 onwards) 
• in 2021, overall vaccination counts for Hexavalent and MMR vaccine remain lower at 
4.0 and 7.9 percentage points lower on week 4 in 2021 compared to week 4 in 2019. 
Vaccination counts were also 0.3 and 10.5 percent change lower on week 4 in 2021 
compared to week 4 in 2020, respectively 
 
Early vaccine coverage 
Early vaccine coverage data uploaded on ImmForm is extracted at 6 months of age to assess 
vaccine coverage for Hexavalent vaccine doses 1 to 3, and at 18 months to assess vaccine 
coverage for MMR1. Vaccine coverage data extracted from ImmForm up to December 2020 
indicates that: 
 
• 85.4% of infants completed the 3-dose course of Hexavalent vaccine by 6 months of 
age – this is 2.7% fewer infants compared to December 2019. Data extracted in 
November and December 2020 also showed a fall in infants receiving Hexavalent 
dose 1 compared to monthly extracts from August to October 2020 
• for children scheduled to receive MMR1 vaccine from March 2020 onwards, vaccine 
coverage measured at 18 months of age remains approximately 86% - this is 2% 
lower than 2019. The WHO coverage target for MMR1 is 95% coverage by 24 months  
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All children who have missed out on their routine vaccinations during the COVID-19 pandemic, 
remain eligible for their vaccines. As physical distancing and lockdown measures change 
throughout the course of the pandemic it is possible that there may be further impact on primary 
immunisations. It is therefore important for General Practitioners and local teams to continue 
offering routine immunisations, check that any infants or children impacted during the pandemic 
are rescheduled for their immunisation and, where required, consider implementing catch-up or 
recovery plans. 
 
Official vaccine coverage estimates for England reflecting coverage from March 2020 onwards 
will be assessed during 2021 in the COVER (Cover of vaccination evaluated rapidly) when 
children reach their first, second, or fifth birthday. 
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Introduction 
 
On 23 March 2020 (week 13), in response to the COVID-19 pandemic, physical distancing 
measures were introduced in England which included school closures, stopping gatherings, 
non-essential use of public transportation and individuals being advised to work from home [1, 
2]. Advice from the Joint Committee on Vaccination and Immunisation (JCVI) on routine 
childhood immunisations stated that children should continue to receive vaccinations according 
to the national schedule throughout the lockdown [3]. Furthermore, on 14 October 2020 (week 
42), a 3-tier approach was introduced where different regions in England were assigned varying 
according to defined tiers and from 5 November (week 45), England returned into nation-wide 
lockdown [4]. On 2 December, the national lockdown ended, and the local 3-tier approach was 
reinstated across the country [5]. However, due to the emergence of a new variant of COVID-
19, cases and hospital admissions dramatically increased and the nation returned to lockdown 
on 5 January 2021 [6]. 
 
In England, childhood immunisations are offered according to the routine immunisation 
schedule [7]. Childhood vaccine coverage is routinely assessed in quarterly COVER (Cover of 
vaccination evaluated rapidly) programme reports for children who reached their first, second, 
or fifth birthday [8]. The COVER reports display the official vaccine coverage estimates for 
England. Although the most recent COVER report largely reflects vaccines administered prior to 
the end of 2019, before the COVID-19 pandemic started,  it stated that a contributing factor to 
the observed decreases in coverage for some vaccines in some areas presented in the quarter 
may be due to some children who, having missed some of their routine immunisations when 
first scheduled but who otherwise might have caught up by their first, second or fifth birthday, 
having been impacted by the lockdown and/or local restrictions from late March 2020 onwards. 
 
Due to the timing of data extractions for the COVER collection, it will not be possible to assess 
the full impact of COVID-19 on primary immunisations until later in 2021, when the official 
COVER statistics reflecting vaccines scheduled from March 2020 onwards are assessed.  
 
The purpose of this report therefore is to provide an interim analysis using alternative data 
sources to assess the impact of COVID-19 on primary immunisations in England at a younger 
age than the routinely collected data. To evaluate the early impact of COVID-19 on the delivery 
of childhood vaccinations, 2 datasets have been analysed: 
 
1. An assessment of aggregated weekly vaccination counts from 2019, 2020 and 2021 for 
dose 1 Hexavalent (Diphtheria, Tetanus, Pertussis (whooping cough), Polio, Haemophilus 
influenzae type b (Hib) and Hepatitis B) delivered to infants 6 months and younger and 
MMR1 (fist dose of Measles, Mumps and Rubella vaccine) to children between the ages of 
12 and 18 months provided by the GP IT supplier The Phoenix Partnership (TPP)1. 
                                            
1 TPP supplies SystmOne which is an electronic patient record used by more than 2,600 primary care practices in 
the UK 
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2. An early assessment of national vaccine coverage from aggregated GP vaccine coverage 
data for dose 1, 2 and 3 of Hexavalent vaccines at 6 months, and MMR1 at 18 months, 
collected monthly via ImmForm2. The ImmForm coverage data provides interim estimates of 
vaccine coverage ahead of the official COVER statistics covering cohorts impacted by 
COVID-19, assessed at 12 and 24 months of age, that will be published later in 2021. 
 
This report will summarise vaccination counts for dose 1 Hexavalent and MMR1 updated 
weekly from TPP in 2021 compared to 2019 and 2020 for the age groups stated above. This 
report will also summarise vaccine coverage extracted up to December 2020 for dose 1, 2 and 
3 of Hexavalent vaccine at 6 months compared to coverage in 2019, and vaccine coverage up 
to December 2020 for dose 1 MMR at 18 months compared to 2019. 
 
Target audience 
This report is aimed for those who monitor and support the routine immunisation programme in 
England at both a local and national level.  
 
  
                                            
2 ImmForm is the system used by Public Health England to record vaccine coverage data for some immunisation 
programmes and to provide vaccine ordering facilities for the NHS 
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Methods 
 
The Hexavalent and MMR vaccines were selected for these analyses as a proxy for routine 
primary immunisations scheduled before 1 year of age and immunisations scheduled from 1 
year of age, respectively, to provide an initial indication of the impact of COVID-19 on all 
primary immunisation programmes. 
 
Monitoring weekly vaccination counts provided by TPP 
Aggregated weekly counts of the dose 1 Hexavalent delivered to infants 6 months and younger 
and dose 1 MMR to children between the ages of 12 and 18 months were provided by TPP for 
all weeks in 2019, 2020, and the first 4 weeks of 2021. Weekly trends in vaccination counts 
were compared between 2019, 2020 and 2021.  
 
Early monitoring vaccine coverage 
GP practice-level vaccine coverage data automatically uploaded via participating GP IT 
suppliers to the ImmForm website on a monthly basis was used to provide an early assessment 
of vaccine coverage for some of the routine childhood vaccinations. This data is validated and 
analysed by PHE to check data completeness, to identify and query any anomalous results, and 
to describe epidemiological trends. Vaccine coverage is calculated as the number of infants 
reaching a target age and receiving a vaccine(s) as a proportion of the total number of infants at 
the target age registered at the GP practice. 
 
Vaccine coverage estimates were extracted from ImmForm on a monthly basis for all children 
who reached 6 months or 18 months of age in that calendar month. Vaccine coverage 
estimates for Hexavalent vaccines 1, 2 and 3 were estimated when children reached 6 months 
of age, whilst vaccine coverage estimates for MMR1 were estimated when children reached 18 
months of age. Vaccine coverage estimates for a different cohort of children were therefore 
extracted each month. To assess the potential impact of COVID-19, we compared vaccine 
coverage data extracted from ImmForm from 2020 with the equivalent month in 2019.  
Figure 1 shows the recommended scheduled timing of the Hexavalent dose 1, 2 and 3, and 
MMR1 vaccinations, and compares the timing of the ImmForm and CHIS extractions.   
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Figure 1. Timeline from when infants are scheduled for their first, second and third dose 
of hexavalent vaccine and first dose of MMR vaccine and the time when ImmForm and 
CHIS data are extracted.  
 
Tables A1 and A2 (Appendix) show how monthly ImmForm data extracted in 2020 relates to the 
recommended schedule for Hexavalent and MMR1 vaccines. Data from 2019 was extracted in 
the same way to enable the comparison between 2020 and 2019. If COVID-19 had impacted 
vaccine delivery in a specific calendar month, this would be reflected in the Immform data in 
different months depending on the particular vaccines effected. For example, if COVID-19 had 
impacted vaccinations scheduled in April 2020, we would expect to see this reflected in the 
ImmForm data in June 2020 for Hexavalent dose 3, July 2020 for Hexavalent dose 2, August 
2020 for Hexavalent dose 1 and October 2020 for MMR1 (Tables A1 and A2). 
 
  
Impact of COVID-19 on childhood vaccination counts to week 4, 2021, and coverage to December 2020 (England) 
Health Protection Report Volume 15 Number 3 
 
8 
Results 
 
Vaccination counts provided by TPP 
TPP represents approximately 38% of data for all practices in England. By week 4, vaccination 
counts from TPP general practices in 156 CCGs, that were in operation in from 2019 to 2021, 
were extracted and are shown in Table 1. 
 
Table 1. Vaccination counts for Hexavalent and MMR vaccines in 2019, 2020 and 2021 
Vaccine Cumulative counts to week 4 2019 
Cumulative counts 
to week 4 2020 
Cumulative counts to 
week 4 2021* 
Dose 1 
Hexavalent 
17,510 15,478 13,279 
Dose 1 MMR 17,304 16,002 12,911 
*Please note lower numbers in 2021 are due to week 1 only included 3 days as 2020 had 53 weeks 
 
The weekly data (Figures 2 to 4) shows that for both Hexavalent 1 and MMR 1, vaccination 
counts decreased substantially in the first weeks after the introduction of physical distancing 
compared to the same period in 2019 (weeks 13 to 15). Vaccination counts then increased in 
2020 weeks 16 and 17 despite physical distancing measures remaining in place [1]. 
 
Since week 17, in 2020, vaccination counts for both MMR1 and Hexavalent remain stable with 
no indication of sudden drops in immunisations delivered during the tiered restrictions (weeks 
43 to 45) or during the introduction of the second national lockdown (weeks 45 onwards). 
 
A drop in counts has been observed in Hexavalent coverage for week 4 in 2021 compared to 
the same week in 2019 and should continue to be monitored in upcoming weeks. Direct 
comparisons for the weekly data between 2019, 2020 and 2021 should be made with caution 
since the days do not map the same weeks (week 1 data for 2021 only accounts for 3 days). 
 
It is also important to note that school holidays and bank holidays occur in different weeks in 
2019, 2020 and 2021, and therefore can cause weekly differences. Decreases in vaccination 
counts have been observed in 2019 and 2020 during school holidays, which may be in different 
weeks (Figures 2 to 5) and will likely be observed in 2021.  
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Figure 2: Dose 1 Hexavalent vaccination counts in infants younger than 6 months in TPP 
practices in operation in both 2019, 2020 and 2021 in England by week in 2019, 2020 and 
2021* 
 
* School holidays (often coinciding with family holidays) for are for the 2020 calendar year. These holidays may 
vary slightly by year and by local area. School holidays for the 2019/20 academic year were in weeks 43, 52, 53, 1, 
8, 15, 16, 19, 22, 30 to 36. School holidays for the 2020/21 academic year are in weeks 44, 52, 53, 7, 13, 14, 18, 
22, 29 to 35. 
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Figure 3: Dose 1 MMR vaccination counts in infants younger than 6 months in TPP 
practices in operation in both 2019,2020 and 2021 in England by week in 2019, 2020 and 
2021* 
 
* School holidays for are for the 2020 calendar year. These holidays may vary slightly by year and by local area. 
School holidays for the 2019/20 academic year were in weeks 43, 52, 53, 1, 8, 15, 16, 19, 22, 30 to 36. School 
holidays for the 2020/21 academic year are in weeks 44, 52, 53, 7, 13, 14, 18, 22, 29 to 35. 
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Figure 4: Percent change in dose 1 Hexavalent (in infants under 6 months) counts in 2021 
compared to 2019 and counts in 2020 compared to 2019, by week in TPP practices open 
in 2019, 2020 and 2021 in England 
 
 
* Direct comparisons for the weekly data between 2019, 2020 and 2021 should be made with caution since the 
days do not map the same weeks (week 1 data for 2021 only accounts for 3 days) 
 
  
-120.0%
-100.0%
-80.0%
-60.0%
-40.0%
-20.0%
0.0%
1 2 3 4 Overall
Pe
rc
en
t C
ha
ng
e 
 
Week 
2020 compared to 2019 2021 compared to 2019
Impact of COVID-19 on childhood vaccination counts to week 4, 2021, and coverage to December 2020 (England) 
Health Protection Report Volume 15 Number 3 
 
12 
Figure 5: Percent change in dose 1 MMR 1 vaccination (in infants ages 12 to 18 months) 
counts in 2021 compared to 2019 and counts in 2020 compared to 2019, by week in TPP 
practices open in 2019, 2020 and 2021 in England 
 
 
 
* Direct comparisons for the weekly data between 2019, 2020 and 2021 should be made with caution since the 
days do not map the same weeks (week 1 data for 2021 only accounts for 3 days) 
 
  
-120.0%
-100.0%
-80.0%
-60.0%
-40.0%
-20.0%
0.0%
20.0%
1 2 3 4 Overall
Pe
rc
en
t C
ha
ng
e 
 
Week 
2020 compared to 2019 2021 compared to 2019
Impact of COVID-19 on childhood vaccination counts to week 4, 2021, and coverage to December 2020 (England) 
Health Protection Report Volume 15 Number 3 
 
13 
Early vaccine coverage assessment in England 
Monthly vaccine coverage data are available on ImmForm for at least 92% of general practices 
since January 2019, and for more than 95% of practices for most of this period.  
 
Hexavalent Vaccine 
Comparing early vaccine coverage estimates for 2020 to those for 2019 shows there has been 
a decrease in vaccine coverage measured at 6 months of age for Hexavalent doses 1, 2 and 3 
since April 2020 (Table 2). Of the 3 vaccine doses, the largest percentage decrease was seen 
in Hexavalent 3 vaccine, indicating a substantial decrease in the percentage of children who 
complete the full 3 vaccine course by 6 months of age.   
 
 
Table 2. Vaccine coverage for dose 1, 2 and 3 of the Hexavalent vaccine by survey month 
(extracted at 6-month age cohorts) in 2019 and 2020 
 
Survey 
month  
Hexavalent dose 1 (%) Hexavalent dose 2 (%) Hexavalent dose 3 (%) 
2019 2020 
Percentage 
point 
difference 
2020 
compared to 
2019 
2019 2020 
Percentage 
point 
difference 
2020 
compared 
to 2019 
2019 2020 
Percentage 
point 
difference 
2020 
compared 
to 2019 
January 96.1 96.2 0.1 93.5 93.7 0.3 87.7 88.5 0.8 
February 95.9 96.3 0.4 93.1 93.8 0.7 87.2 88.4 1.2 
March 96.0 96.6 0.6 93.4 94.0 0.5 88.1 88.6 0.5 
April 96.2 95.9 -0.3 93.9 92.4 -1.5 88.8 84.1 -4.7 
May 96.5 96.0 -0.5 94.3 92.0 -2.3 89.4 83.9 -5.5* 
June 96.2 95.8 -0.4 93.9 91.9 -2.0* 88.8 85.3 -3.5* 
July 96.4 95.6 -0.8* 94.0 92.4 -1.6* 89.1 86.5 -2.7* 
August 96.3 95.9 -0.4* 94.0 93.3 -0.7* 89.0 87.6 -1.4* 
September 96.4 96.0 -0.4* 93.9 93.3 -0.6* 88.9 87.1 -1.8* 
October 96.2 95.9 -0.3* 93.9 93.0 -0.9* 89.2 86.3 -3.0* 
November 96.1 95.5 -0.6* 93.6 92.5 -1.1* 88.7 85.8 -2.9* 
December 96.2 95.7 -0.6* 93.7 92.5 -1.3* 88.1 85.4 -2.7* 
* Indicates cohorts of infants scheduled to receive their vaccine from March 2020 onwards 
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Infants who were scheduled from 8 weeks of age for dose 1 Hexavalent vaccine in March 2020 
onwards are reflected in the ImmForm vaccine coverage estimates at 6 months of age from July 
2020 onwards. Hexavalent 1 coverage trends for 2020 are broadly similar compared to 2019, 
with the largest decrease of 0.8 percentage points seen in the July 2020 data for infants 
scheduled to receive this vaccine in March 2020 (Figure 6). This has been followed by a 
decrease of 0.6 percentage points in the November and December 2020 data for infants 
scheduled to receive this vaccine in July and August 2020 (Figure 6). 
 
Infants scheduled from 12 weeks of age for dose 2 Hexavalent vaccine from March 2020 
onwards are reflected in June ImmForm coverage data onwards. Vaccine coverage for dose 2 
Hexavalent in June and July 2020 was lower than coverage estimates in June and July 2019, 
indicating that infants scheduled for their second dose of Hexavalent vaccine in March and April 
have most likely been impacted by COVID-19. Infants turning 6-months-old in the August-to-
October extracts on ImmForm and who were scheduled for dose 2 Hexavalent in May and July 
appear less impacted by COVID-19 and coverage is more aligned with the 2019 estimates 
(Figure 6). However, this has been followed by a slight decrease in coverage of 1.1 and 1.3 
percentage points in the November and December 2020 data, respectively, for infants 
scheduled to receive their second dose of Hexavalent vaccine from August and September 
2020.  
 
Infants scheduled from 16 weeks of age for dose 3 Hexavalent vaccine from March 2020 
onwards are reflected in May ImmForm coverage data onwards. Vaccine coverage for dose 3 
Hexavalent in May 2020 was substantially lower compared to coverage in May 2019, indicating 
that infants scheduled for their third dose of Hexavalent in March have most likely been 
impacted by COVID-19. Infant scheduled for dose 3 Hexavalent vaccine from April to July 
(turning 6-months-old in the June to September extracts on ImmForm, respectively) still appear 
impacted by COVID-19 though the percentage decrease is smaller than in previous months 
(Figure 6). However, Hexavalent coverage for dose 3 from September to December 2020 
(infants scheduled for dose 3 Hexavalent in July through to October 2020) is again indicating a 
downward trend in coverage. 
 
Hexavalent coverage for dose 2 in April and May 2020 and for dose 3 in April 2020 is lower than 
coverage during these months in 2019. These reflects hexavalent vaccines that were scheduled 
for administration before the national lockdown in England was introduced in March 2020 
indicating that these children may have missed their initial scheduled vaccination appointment, 
but were potentially unable to catch-up by 6 months of age as the social distancing measures 
began (Figure 6). 
 
Similarly, reduced completed coverage may yet be seen among those infants who were 
scheduled to receive their first dose of Hexavalent vaccine during April and May (when the 
social distancing measures were still in place) but missed or otherwise delayed that opportunity. 
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Figure 6: Vaccine coverage for dose 1, 2 and 3 of the Hexavalent vaccine by survey 
month in 2019 and 2020 
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MMR1 Vaccine 
Comparing vaccine coverage estimates measured at 18 months of age for MMR1 for 2020 to 
2019, there was a monthly decrease from April 2020 onwards. From August 2020 onwards, the 
decrease has been approximately 2% (Table 3 and Figure 7). 
 
The August ImmForm coverage data reflects children first scheduled for MMR1 at 12 months of 
age from February 2020 onwards (before the national lockdown). The 2.1% decrease in this 
cohort indicates that these children may have missed their initial scheduled vaccination 
appointment, but were potentially unable to catch-up by 18 months of age as social distancing 
measures began. 
 
Children scheduled from 12 months of age for MMR1 from March 2020 onwards are reflected in 
September ImmForm coverage data onwards. Vaccine coverage for MMR1 between 
September and December 2020 was lower than coverage estimates between September and 
December 2019, indicating that infants scheduled for their MMR1 vaccine between March and 
June have most likely been impacted by COVID-19. The impact of COVID-19 on MMR1 
coverage will continue to be monitored in the January 2021 extract which will reflect children 
that turned 12 months in July 2020. 
 
In both 2019 and 2020, MMR1 coverage is substantially below the WHO target of 95% 
coverage at 24 months.  
 
Table 3. Vaccine coverage for dose 1 of the MMR vaccine by survey month (extracted at 
18-month age cohorts) in 2019 and 2020 
 MMR dose 1 (%) 
Survey month 2019 2020 Percentage point difference 2020 compared to 2019 
January 87.3 88.1 0.8 
February 87.2 88.3 1.0 
March 87.2 88.2 1.0 
April 87.8 87.6 -0.2 
May 88.2 87.9 -0.3 
June 87.8 87.3 -0.5 
July 88.2 87.1 -1.1 
August 88.6 86.5 -2.1 
September 88.4 86.4 -2.0* 
October 88.6 86.5 -2.1* 
November 88.4 86.3 -2.1* 
December 88.1 86.2 -1.9* 
 
* Indicates cohorts of infants scheduled to receive their vaccine from March 2020 onwards 
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Figure 7: Vaccine coverage for MMR1 at 18 months of age by survey month in 2019 and 
2020 
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Discussion 
 
This report presents an early indication of the impact of COVID-19 on routine childhood 
immunisations in England, using data from vaccine counts and early vaccine coverage data. 
The purpose of this report is to provide early coverage estimates to those who monitor and 
support the routine immunisation programme at both a local and national level, before the 
official 12 and 24 month estimates of vaccine coverage during the COVID-19 pandemic are 
analysed by the COVER programme. 
 
Together the vaccine counts data and the vaccine coverage data both point towards a 
substantial decrease in children receiving routine childhood immunisations in 2020 compared to 
2019. Since April 2020, fewer infants have completed the full course of 3 Hexavalent vaccines 
by 6 months of age, and fewer children have received MMR1 by 18 months of age. The initial 
decrease in vaccination may be associated with COVID-19 messaging about staying home 
initially overwhelming the messaging that the routine immunisation programme was to remain 
operating as usual [1]. Additionally, anecdotal information indicated that in some areas, to 
ensure safe and best practice, GPs had to reschedule appointments in the initial weeks to 
ensure social distancing within GP practices. Since the initial weeks, overall, decreased 
vaccination coverage and lower counts have continued throughout the pandemic. 
 
Vaccine Counts 
At the introduction of the physical distancing measures on 23 March 2020 (week 13), 
vaccination counts for MMR1 and dose 1 Hexavalent fell compared to 2019. Vaccination counts 
for both vaccines began to rise in weeks 16 and 17 and were comparable to 2019 counts, and 
to counts in 2020 prior to the COVID-19 pandemic, indicating that the initial drop had recovered. 
Vaccination counts do seem to have remained stable in the tiered restrictions and during the 
second lockdown. However, the overall vaccination counts in 2021 for dose 1 Hexavalent and 
MMR1 vaccines are still lower than the 2019 and 2020 counts indicating fewer vaccines have 
been delivered. 
 
Vaccine Coverage 
Early assessment of age-specific vaccine coverage allows local areas to assess performance 
before children reach the age that formal vaccine coverage is evaluated, therefore giving local 
teams an opportunity to catch-up where shortfalls have been identified. 
 
Whilst vaccine coverage for Hexavalent 1 in 2020 is broadly similar to vaccine coverage in 
2019, Hexavalent doses 2 and 3 coverage is lower in 2020 compared to 2019, indicating fewer 
children have completed the full course. Whilst the size of the decrease in vaccine coverage 
was smaller in the August and September monthly extracts, it is concerning that coverage for 
Hexavalent dose 3 fell again in the October, November and December monthly extracts. 
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Furthermore, an observed drop in Hexavalent dose 1 coverage has been observed in 
December 2020 compared to December 2019. 
 
Vaccine coverage for MMR1 in 2020 is lower than 2019, and in both years, coverage is far short 
of the WHO target of 95% by 24 months. Coverage measured at 18 months of age is only just 
beginning to monitor children who were scheduled to receive the vaccine in the initial months of 
lockdown. 
 
Although data presented in the most recent COVER report largely reflects vaccines 
administered prior to the end of 2019, before the COVID-19 pandemic started, children who 
missed some of their routine immunisations when first scheduled and otherwise might have 
caught up by the first, second or fifth birthday, may have been impacted by the lockdown and/or 
local restrictions from late March onwards. This data aligns with our findings in Hexavalent and 
MMR vaccine coverage at 6 and 18 months among children eligible prior to the pandemic.  
 
Strengths and limitations 
This interim analysis of early vaccine coverage for children before they reach the target ages of 
12 and 24 months used for routine surveillance systems provides a timelier assessment of the 
impact of COVID-19 on primary immunisations in England. The report helps monitor national 
level vaccine coverage throughout the pandemic. 
 
The vaccination counts data presented in this report was the first available data extracted to 
monitor the impact of COVID-19 on primary immunisations in England. Weekly vaccination 
counts do show an early assessment and may predict future drops in vaccine coverage 
extracted in later ImmForm extracts. However, it is important to note that the data is only from 
one GP IT supplier (TPP) and coverage estimates cannot be calculated without age-specific 
denominator data. Additionally, some regions are less represented than others and therefore do 
not represent data for all of England. This data should therefore be viewed with some caution 
and will not necessarily reflect vaccination count trends at a local level. The drop-in vaccination 
counts may be explained by a slightly smaller cohort or a small decline in coverage [2]. 
 
Vaccine coverage estimates from ImmForm show early estimates of vaccine coverage. This 
data allows for local performance management where areas can assess which cohorts may 
require further follow-up for vaccination. Vaccine coverage estimates are extracted by GP IT 
suppliers, based on a set list of SNOMED CT codes, therefore these estimates only reflect 
coverage for children registered with a GP practice, and that have correct coding in their GP 
record. Furthermore, the ImmForm data is experimental data and to date has only been used 
for performance management purposes - it is not validated at the GP practice level. Smaller 
areas may see greater differences in coverage due to smaller numbers.  
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Conclusion 
Future weekly vaccination counts data from TPP and monthly ImmForm collections will continue 
to monitor any impact of COVID-19 on early vaccine coverage. Vaccine coverage will vary 
across the country and local areas can monitor early estimates of coverage in their areas using 
ImmForm and other data sources to identify areas needing more support. 
 
As physical distancing measures change throughout the course of the pandemic and the risk of 
other infectious diseases circulating increases it is of utmost importance that GPs continue 
offering routine immunisations, check and recall those who have not received a vaccine and, 
where required, recovery plans should be set in place to address any drop in vaccine coverage 
observed since the beginning of the pandemic. 
 
Local areas should engage with specific cohorts of infants and children who may have been 
affected when social distancing measures were introduced, to ensure that they are rescheduled 
for their immunisations. These children will remain eligible and will be assessed in the 
appropriate age-specific routine quarterly coverage estimates in the COVER publication. 
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Appendices 
 
Table A1. Monthly data extracts from ImmForm survey for Hexavalent vaccine, showing 
month of birth and the month vaccine is first due.   
 
Hexavalent Vaccine 
Month data is 
extracted from 
ImmForm 
Age at 
which data 
is extracted 
Month of 
birth Month vaccine first due 
   Dose 1 
(8 weeks 
old) 
Dose 2 
(12 weeks 
old) 
Dose 3 
(16 weeks 
old) 
Jan 2020 6 months Jul 2019 Sep 2019 Oct 2019 Nov 2019 
Feb 2020 6 months Aug 2019 Oct 2019 Nov 2019 Dec 2019 
Mar 2020 6 months Sep 2019 Nov 2019 Dec 2019 Jan 2020 
Apr 2020 6 months Oct 2019 Dec 2019 Jan 2020 Feb 2020 
May 2020 6 months Nov 2019 Jan 2020 Feb 2020 Mar 2020 
Jun 2020 6 months Dec 2019 Feb 2020 Mar 2020 Apr 2020 
Jul 2020 6 months Jan 2020 Mar 2020 Apr 2020 May 2020 
Aug 2020 6 months Feb 2020 Apr 2020 May 2020 Jun 2020 
Sep 2020 6 months Mar 2020 May 2020 Jun 2020 Jul 2020 
Oct 2020 6 months Apr 2020 Jun 2020 Jul 2020 Aug 2020 
Nov 2020 6 months May 2020 Jul 2020 Aug 2020 Sep 2020 
Dec 2020 6 months Jun 2020 Aug 2020 Sep 2020 Oct 2020 
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Table A2. Monthly data extracts from ImmForm survey for MMR1 vaccine, showing 
month of birth and the month vaccine is first due.   
 
MMR1 
Month data is extracted 
from ImmForm  
Age at which data 
is extracted Month of birth 
Month vaccine 
first due 
Jan 2020 18 months Jul 2018 Jul 2019 
Feb 2020 18 months Aug 2018 Aug 2019 
Mar 2020 18 months Sep 2018 Sep 2019 
Apr 2020 18 months Oct 2018 Oct 2019 
May 2020 18 months Nov 2018 Nov 2019 
Jun 2020 18 months Dec 2018 Dec 2019 
Jul 2020 18 months Jan 2019 Jan 2020 
Aug 2020 18 months Feb 2019 Feb 2020 
Sep 2020 18 months Mar 2019 Mar 2020 
Oct 2020 18 months Apr 2019 Apr 2020 
Nov 2020 18 months May 2019 May 2020 
Dec 2020 18 months Jun 2019 Jun 2020 
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